Topic

Pennsylvania

A collection of 524 issues

Do You Qualify for Defitelio Coverage by UnitedHealthcare in Pennsylvania? Decision Tree & Next Steps

Answer Box: Your Path to Defitelio Coverage Getting Defitelio (defibrotide) covered by UnitedHealthcare in Pennsylvania requires prior authorization for hepatic VOD/SOS with organ dysfunction post-HSCT. You're likely eligible if you have confirmed hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem cell transplant. Start by

Lowering Out-of-Pocket for Xospata (gilteritinib) with Aetna (CVS Health) in Pennsylvania: Copay, Tiering & Assistance

Answer Box: Getting Xospata (gilteritinib) Covered by Aetna (CVS Health) in Pennsylvania Xospata requires prior authorization from Aetna (CVS Health) with documented FLT3 mutation testing and relapsed/refractory AML diagnosis. The medication costs approximately $28,979 per 30-day supply but copay assistance can reduce costs to $0 for commercially insured

How to Get Stelara (Ustekinumab) Covered by Cigna in Pennsylvania: Coding, Appeals, and Step Therapy Guide

Answer Box: Getting Stelara Covered by Cigna in Pennsylvania Fastest path to approval: Complete Cigna's prior authorization form with proper ICD-10 codes (L40.0 for plaque psoriasis, K50.x for Crohn's), document step therapy failures, and include specialist notes showing medical necessity. If denied, Pennsylvania'

Myths vs. Facts: Getting Rapivab (peramivir) Covered by UnitedHealthcare in Pennsylvania

Answer Box: Getting Rapivab Covered by UnitedHealthcare in Pennsylvania Rapivab (peramivir) requires prior authorization through UnitedHealthcare's OptumRx and is typically non-formulary, but approval is possible with proper documentation. Key requirements: symptoms within 48 hours, positive flu test, and documented failure/contraindication of oral antivirals. If denied, Pennsylvania'

Myths vs. Facts: Getting Evrysdi (risdiplam) Covered by Humana in Pennsylvania - 2025 Appeals Guide

Answer Box: Getting Evrysdi Covered by Humana in Pennsylvania Evrysdi (risdiplam) requires prior authorization from Humana Medicare Advantage plans in Pennsylvania. Key requirements include genetic confirmation of SMA diagnosis and baseline motor function assessment. If denied, Pennsylvania's new external review program overturns 53% of appeals. First step: Have

Renewing Soliris (Eculizumab) Approval with Aetna (CVS Health) in Pennsylvania: Complete 2025 Guide

Answer Box: Renewing Soliris (Eculizumab) with Aetna (CVS Health) in Pennsylvania Your Soliris renewal requires updated clinical documentation showing ongoing therapeutic response and up-to-date meningococcal vaccination. Submit your renewal request at least 2 weeks before your current authorization expires to avoid treatment interruptions. If denied, Pennsylvania's new external

Get Chenodal (chenodiol) Covered by Blue Cross Blue Shield in Pennsylvania: ICD-10, NDC, and Billing Guide

Answer Box: Getting Chenodal Covered in Pennsylvania Chenodal (chenodiol) requires prior authorization from all Blue Cross Blue Shield plans in Pennsylvania, including Highmark and Independence Blue Cross. Step 1: Ensure proper ICD-10 coding (K80.20 for radiolucent gallstones). Step 2: Submit PA with imaging proof of radiolucent stones, surgical ineligibility

How to Get Natpara (Parathyroid Hormone) Covered by UnitedHealthcare in Pennsylvania: 2025 Discontinuation Guide

Quick Answer: Natpara Coverage Status in Pennsylvania Natpara (parathyroid hormone) is being discontinued globally by Takeda as of December 31, 2024. UnitedHealthcare in Pennsylvania will only cover existing patients through December 2025, with no new patient starts allowed. If you're currently on Natpara, work with your endocrinologist immediately

How to Get Tegsedi (inotersen) Covered by Cigna in Pennsylvania: Decision Tree, Forms & Appeals

Answer Box: Quick Eligibility Check To get Tegsedi (inotersen) covered by Cigna in Pennsylvania: You need confirmed hATTR polyneuropathy with genetic testing, specialist prescription, REMS enrollment, and often proof you've tried Onpattro (patisiran) first. Submit prior authorization through Express Scripts specialty pharmacy with complete documentation. If denied, use

Blue Cross Blue Shield Pennsylvania Revcovi Coverage: Prior Authorization Requirements and Appeal Process

Answer Box: Getting Revcovi Covered by Blue Cross Blue Shield in Pennsylvania Blue Cross Blue Shield plans in Pennsylvania require prior authorization for Revcovi (elapegademase) to treat ADA-SCID. To qualify: (1) Confirm ADA-SCID diagnosis with enzyme testing showing <1% normal ADA activity, (2) Document that bone marrow transplant failed